Jay Flatley Biography and Net Worth

Director of Illumina

Jay Flatley is the former CEO and director of Illumina. He currently serves as executive chairman.

During his time as CEO, Flatley directed the company’s expansion from microarrays to next-generation sequencing via its 2006 acquisition of Solexa, and more recently from research to clinical and applied markets.

Prior to Illumina, Flatley was co-founder, president, CEO, and a director for Molecular Dynamics, a life sciences company concentrated on genetic discovery and analysis. He remained there until the company’s sale to Amersham Pharmacia Biotech in 1998.

Previously, he served as vice president of engineering and vice president of strategic planning for Plexus Computers. He was also a director for Coherent, a photonics-based solutions provider for commercial and scientific markets.

During Flatley’s tenure at Illumina, the company was recognized multiple times on the Deloitte & Touche “Fast 50” and “Fast 500” lists, and Forbes’ list of the “25 Fastest-Growing Tech Companies” in 2007, 2009 and 2010. It was also named to Fortune’s “100 Fastest-Growing Companies” list in 2010 and 2011. Additionally, MIT Technology Review recognized it as the “World’s Smartest Company” in 2014.

Flatley received his bachelor of arts in economics from Claremont McKenna College. He also received both his bachelor of science and master of science in industrial engineering at Stanford University.

What is Jay T. Flatley's net worth?: The estimated net worth of Jay T. Flatley is at least $7.41 million as of May 26th, 2022. Mr. Flatley owns 92,616 shares of Illumina stock worth more than $7,409,280 as of March 29th. This net worth approximation does not reflect any other assets that Mr. Flatley may own. Learn More about Jay T. Flatley's net worth.
How do I contact Jay T. Flatley?: The corporate mailing address for Mr. Flatley and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at ir@illumina.com. Learn More on Jay T. Flatley's contact information.
Has Jay T. Flatley been buying or selling shares of Illumina?: Jay T. Flatley has not been actively trading shares of Illumina within the last three months. Most recently, Jay T. Flatley sold 4,000 shares of the business's stock in a transaction on Tuesday, May 18th. The shares were sold at an average price of $379.53, for a transaction totalling $1,518,120.00. Following the completion of the sale, the director now directly owns 148,933 shares of the company's stock, valued at $56,524,541.49. Learn More on Jay T. Flatley's trading history.
Who are Illumina's active insiders?: Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Jacob Thaysen (CEO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Jay T. Flatley Insider Trading History at Illumina

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/18/2021	Sell	4,000	$379.53	$1,518,120.00	148,933
5/4/2021	Sell	4,000	$384.15	$1,536,600.00	152,933
4/20/2021	Sell	4,000	$401.83	$1,607,320.00	156,933
4/6/2021	Sell	4,000	$423.44	$1,693,760.00
3/16/2021	Sell	4,000	$421.06	$1,684,240.00	164,933
1/19/2021	Sell	4,000	$382.48	$1,529,920.00	180,933
1/5/2021	Sell	4,000	$365.27	$1,461,080.00	184,933
12/15/2020	Sell	4,000	$348.84	$1,395,360.00	188,933
12/1/2020	Sell	4,000	$323.90	$1,295,600.00
11/17/2020	Sell	3,000	$297.16	$891,480.00	197,933
10/20/2020	Sell	4,000	$321.72	$1,286,880.00	203,933
10/6/2020	Sell	3,000	$317.79	$953,370.00	207,933
9/15/2020	Sell	4,000	$355.22	$1,420,880.00	210,933
9/1/2020	Sell	4,000	$355.35	$1,421,400.00	214,933
8/18/2020	Sell	4,000	$354.03	$1,416,120.00	218,933
7/21/2020	Sell	4,000	$399.00	$1,596,000.00	226,933
7/7/2020	Sell	4,000	$370.22	$1,480,880.00	230,933
6/16/2020	Sell	4,000	$354.93	$1,419,720.00	234,933
5/19/2020	Sell	4,000	$342.34	$1,369,360.00	241,970
5/5/2020	Sell	3,000	$310.37	$931,110.00	245,970
4/21/2020	Sell	3,000	$310.77	$932,310.00	248,970
4/7/2020	Sell	2,000	$284.63	$569,260.00	255,970
2/18/2020	Sell	3,000	$299.00	$897,000.00	255,970
8/28/2019	Sell	3,300	$283.41	$935,253.00	262,733
8/14/2019	Sell	3,300	$288.36	$951,588.00
7/24/2019	Sell	3,300	$304.00	$1,003,200.00	269,316
7/10/2019	Sell	3,300	$376.50	$1,242,450.00	272,616
6/26/2019	Sell	3,300	$358.15	$1,181,895.00	275,916
6/12/2019	Sell	3,300	$334.53	$1,103,949.00	279,216
5/22/2019	Sell	3,300	$304.44	$1,004,652.00	282,516
5/8/2019	Sell	3,300	$318.59	$1,051,347.00	285,816
4/24/2019	Sell	3,300	$321.96	$1,062,468.00
4/10/2019	Sell	3,300	$317.01	$1,046,133.00	331,668
3/27/2019	Sell	3,300	$306.93	$1,012,869.00	338,268
3/13/2019	Sell	3,300	$306.50	$1,011,450.00	338,268
2/27/2019	Sell	3,300	$300.00	$990,000.00	341,568
2/13/2019	Sell	3,300	$293.66	$969,078.00	358,929
1/23/2019	Sell	3,300	$303.53	$1,001,649.00	329,979
1/9/2019	Sell	3,300	$296.20	$977,460.00	333,279
12/26/2018	Sell	3,300	$273.87	$903,771.00	339,879
12/12/2018	Sell	3,300	$334.13	$1,102,629.00	374,859
11/28/2018	Sell	3,300	$321.80	$1,061,940.00	373,410
11/14/2018	Sell	3,300	$312.50	$1,031,250.00	376,710
10/24/2018	Sell	3,300	$310.58	$1,024,914.00	382,304
10/10/2018	Sell	3,300	$321.58	$1,061,214.00	385,604
9/26/2018	Sell	3,300	$360.81	$1,190,673.00	388,904
9/12/2018	Sell	3,300	$351.66	$1,160,478.00	392,204
5/14/2018	Sell	1,460	$268.00	$391,280.00
1/16/2018	Sell	15,000	$243.72	$3,655,800.00	449,201
1/2/2018	Sell	20,000	$223.40	$4,468,000.00	463,436
12/19/2017	Sell	20,000	$215.48	$4,309,600.00	480,476
12/5/2017	Sell	20,000	$212.55	$4,251,000.00	505,980
11/21/2017	Sell	20,000	$211.35	$4,227,000.00	531,717
11/7/2017	Sell	20,000	$210.59	$4,211,800.00	536,717
10/24/2017	Sell	20,000	$210.43	$4,208,600.00	539,176
10/10/2017	Sell	20,000	$203.27	$4,065,400.00
9/26/2017	Sell	20,000	$200.16	$4,003,200.00	539,176
9/12/2017	Sell	20,000	$211.11	$4,222,200.00	539,176
8/29/2017	Sell	22,540	$195.21	$4,400,033.40	539,176
8/28/2017	Sell	2,540	$197.39	$501,370.60	539,176
8/15/2017	Sell	20,000	$194.73	$3,894,600.00	539,176
8/2/2017	Sell	20,000	$176.43	$3,528,600.00	534,176
7/18/2017	Sell	15,000	$170.77	$2,561,550.00	534,176
7/5/2017	Sell	15,000	$172.92	$2,593,800.00	534,176
6/22/2017	Sell	20,000	$178.21	$3,564,200.00	534,176
6/6/2017	Sell	20,000	$180.24	$3,604,800.00	539,176
6/1/2017	Sell	3,320	$180.55	$599,426.00	519,176
5/23/2017	Sell	15,000	$175.53	$2,632,950.00	534,176
5/9/2017	Sell	20,000	$184.14	$3,682,800.00	539,176
8/23/2016	Sell	20,000	$172.99	$3,459,800.00	508,061
8/15/2016	Sell	10,000	$170.00	$1,700,000.00	498,061
8/9/2016	Sell	10,000	$165.97	$1,659,700.00	498,061
8/1/2016	Sell	10,000	$170.00	$1,700,000.00	498,061
7/26/2016	Sell	10,000	$150.00	$1,500,000.00	498,061
7/18/2016	Sell	10,000	$150.00	$1,500,000.00	498,061
4/12/2016	Sell	20,000	$170.05	$3,401,000.00	508,061
3/22/2016	Sell	10,000	$154.18	$1,541,800.00	498,061
3/8/2016	Sell	10,000	$154.49	$1,544,900.00	500,915
2/23/2016	Sell	10,000	$152.49	$1,524,900.00	440,784
1/26/2016	Sell	20,000	$171.70	$3,434,000.00	433,423
1/13/2016	Sell	20,000	$168.81	$3,376,200.00	433,423
12/22/2015	Sell	25,000	$185.38	$4,634,500.00	433,423
12/8/2015	Sell	25,000	$177.11	$4,427,750.00	433,423
11/25/2015	Sell	5,000	$180.00	$900,000.00	423,793
11/24/2015	Sell	20,000	$173.27	$3,465,400.00	423,793
11/16/2015	Sell	10,000	$170.00	$1,700,000.00	423,793
11/10/2015	Sell	10,000	$154.58	$1,545,800.00	423,793
10/15/2015	Sell	10,000	$150.00	$1,500,000.00	424,996
9/22/2015	Sell	25,000	$192.79	$4,819,750.00	424,996
9/8/2015	Sell	25,000	$194.87	$4,871,750.00	424,996
8/27/2015	Sell	25,000	$200.16	$5,004,000.00	424,996
8/13/2015	Sell	25,000	$207.85	$5,196,250.00
7/23/2015	Sell	25,000	$214.87	$5,371,750.00
7/9/2015	Sell	25,000	$218.10	$5,452,500.00
6/25/2015	Sell	25,000	$220.34	$5,508,500.00
6/11/2015	Sell	25,000	$216.41	$5,410,250.00
5/28/2015	Sell	25,000	$208.78	$5,219,500.00
5/14/2015	Sell	25,000	$197.76	$4,944,000.00
4/23/2015	Sell	25,000	$189.57	$4,739,250.00
4/9/2015	Sell	25,000	$184.55	$4,613,750.00
3/26/2015	Sell	25,000	$181.34	$4,533,500.00
2/26/2015	Sell	25,000	$195.73	$4,893,250.00
2/12/2015	Sell	25,000	$194.64	$4,866,000.00
1/22/2015	Sell	25,000	$188.48	$4,712,000.00
1/8/2015	Sell	25,000	$197.62	$4,940,500.00
12/26/2014	Sell	25,000	$186.71	$4,667,750.00
12/11/2014	Sell	25,000	$185.79	$4,644,750.00
11/13/2014	Sell	25,000	$189.32	$4,733,000.00
10/23/2014	Sell	25,000	$189.54	$4,738,500.00
10/9/2014	Sell	25,000	$163.49	$4,087,250.00
9/25/2014	Sell	25,000	$164.43	$4,110,750.00
9/15/2014	Sell	25,000	$176.06	$4,401,500.00
8/28/2014	Sell	30,000	$178.98	$5,369,400.00
7/24/2014	Sell	30,000	$175.43	$5,262,900.00
7/10/2014	Sell	30,000	$172.56	$5,176,800.00
6/26/2014	Sell	30,000	$170.11	$5,103,300.00
6/12/2014	Sell	30,000	$172.25	$5,167,500.00
10/24/2013	Sell	30,000	$92.32	$2,769,600.00
7/25/2013	Sell	20,000	$81.01	$1,620,200.00
7/11/2013	Sell	20,000	$74.90	$1,498,000.00
6/27/2013	Sell	20,000	$74.96	$1,499,200.00
6/13/2013	Sell	20,000	$66.49	$1,329,800.00
5/21/2013	Sell	24,000	$69.39	$1,665,360.00
5/9/2013	Sell	20,000	$66.63	$1,332,600.00
11/8/2012	Sell	5,000	$47.99	$239,950.00

See Full Table

Jay T. Flatley Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Today's Range

Now: $80.00

$79.30

$82.35

50 Day Range

MA: $102.80

$80.00

$141.31

2 Week Range

Now: $80.00

$79.30

$156.66

Volume

1,526,373 shs

Average Volume

2,212,008 shs

Market Capitalization

$12.67 billion

P/E Ratio

N/A

Dividend Yield